<author><surname>Bytzer</surname> <given-names>P.</given-names> </author><author><surname>Talley</surname> <given-names>N.J.</given-names> </author><author><surname>Leemon</surname> <given-names>M.</given-names> </author><author><surname>Young</surname> <given-names>L.J.</given-names> </author><author><surname>Jones</surname> <given-names>M.P.</given-names> </author><author><surname>Horowitz</surname> <given-names>M.</given-names> </author><title>Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults</title><source>Arch Intern Med.</source><year>2001</year><volume>161</volume><fpage>1989</fpage><lpage>1996</lpage>
<author><surname>Ricci</surname> <given-names>J.A.</given-names> </author><author><surname>Siddique</surname> <given-names>R.</given-names> </author><author><surname>Stewart</surname> <given-names>W.F.</given-names> </author><author><surname>Sandler</surname> <given-names>R.S.</given-names> </author><author><surname>Sloan</surname> <given-names>S.</given-names> </author><author><surname>Farup</surname> <given-names>C.E.</given-names> </author><title>Upper gastrointestinal symptoms in a US national sample of adults with diabetes</title><source>Scand J Gastroenterol.</source><year>2000</year><volume>35</volume><fpage>152</fpage><lpage>159</lpage>
<author><surname>Samsom</surname> <given-names>M.</given-names> </author><author><surname>Bharucha</surname> <given-names>A.</given-names> </author><author><surname>Gerich</surname> <given-names>J.E.</given-names> </author><title>Diabetes mellitus and gastric emptying: questions and issues in clinical practice</title><source>Diabetes Metab Res Rev.</source><year>2009</year><volume>25</volume><fpage>502</fpage><lpage>514</lpage>
<author><surname>Patrick</surname> <given-names>A.</given-names> </author><author><surname>Epstein</surname> <given-names>O.</given-names> </author><title>Review article: gastroparesis</title><source>Aliment Pharmacol Ther.</source><year>2008</year><volume>27</volume><fpage>724</fpage><lpage>740</lpage>
<author><surname>Frank</surname> <given-names>J.W.</given-names> </author><author><surname>Saslow</surname> <given-names>S.B.</given-names> </author><author><surname>Camilleri</surname> <given-names>M.</given-names> </author><author><surname>Thomforde</surname> <given-names>G.M.</given-names> </author><author><surname>Dinneen</surname> <given-names>S.</given-names> </author><author><surname>Rizza</surname> <given-names>R.A.</given-names> </author><title>Mechanism of accelerated gastric emptying of liquids and hyperglycemia in patients with type II diabetes mellitus</title><source>Gastroenterology</source><year>1995</year><volume>109</volume><fpage>755</fpage><lpage>765</lpage>
<author><surname>Intagliata</surname> <given-names>N.</given-names> </author><author><surname>Koch</surname> <given-names>K.L.</given-names> </author><title>Gastroparesis in type 2 diabetes mellitus: prevalence, etiology, diagnosis, and treatment</title><source>Curr Gastroenterol Rep.</source><year>2007</year><volume>9</volume><fpage>270</fpage><lpage>279</lpage>
<author><surname>Barnett</surname> <given-names>J.L.</given-names> </author><author><surname>Owyang</surname> <given-names>C.</given-names> </author><title>Serum glucose concentration as a modulator of interdigestive gastric motility</title><source>Gastroenterology</source><year>1988</year><volume>94</volume><fpage>739</fpage><lpage>744</lpage>
<author><surname>Lysy</surname> <given-names>J.</given-names> </author><author><surname>Israeli</surname> <given-names>E.</given-names> </author><author><surname>Strauss-Liviatan</surname> <given-names>N.</given-names> </author><author><surname>Goldin</surname> <given-names>E.</given-names> </author><title>Relationships between hypoglycaemia and gastric emptying abnormalities in insulin-treated diabetic patients</title><source>Neurogastroenterol Motil.</source><year>2006</year><volume>18</volume><fpage>433</fpage><lpage>440</lpage>
<author><surname>Horowitz</surname> <given-names>M.</given-names> </author><author><surname>Jones</surname> <given-names>K.L.</given-names> </author><author><surname>Rayner</surname> <given-names>C.K.</given-names> </author><author><surname>Read</surname> <given-names>N.W.</given-names> </author><title>&#8220;Gastric&#8221; hypoglycaemia &#8212; an important concept in diabetes management</title><source>Neurogastroenterol Motil.</source><year>2006</year><volume>18</volume><fpage>405</fpage><lpage>407</lpage>
<author><surname>Ma</surname> <given-names>J.</given-names> </author><author><surname>Rayner</surname> <given-names>C.K.</given-names> </author><author><surname>Jones</surname> <given-names>K.L.</given-names> </author><author><surname>Horowitz</surname> <given-names>M.</given-names> </author><title>Diabetic gastroparesis: diagnosis and management</title><source>Drugs</source><year>2009</year><volume>69</volume><fpage>971</fpage><lpage>986</lpage>
<author><surname>Hejazi</surname> <given-names>R.</given-names> </author><author><surname>McCallum</surname> <given-names>R.</given-names> </author><title>Diabetic gastroparesis: a review of medical treatments</title><source>Pract Gastroenterol.</source><year>2009</year><volume>6</volume><fpage>10</fpage><lpage>20</lpage>
<author><surname>Forster</surname> <given-names>J.</given-names> </author><author><surname>Damjanov</surname> <given-names>I.</given-names> </author><author><surname>Lin</surname> <given-names>Z.</given-names> </author><author><surname>Sarosiek</surname> <given-names>I.</given-names> </author><author><surname>Wetzel</surname> <given-names>P.</given-names> </author><author><surname>McCallum</surname> <given-names>R.W.</given-names> </author><title>Absence of the interstitial cells of Cajal in patients with gastroparesis and correlation with clinical findings</title><source>J Gastrointest Surg.</source><year>2005</year><volume>9</volume><fpage>102</fpage><lpage>108</lpage>
<author><surname>Lin</surname> <given-names>Z.</given-names> </author><author><surname>Sarosiek</surname> <given-names>I.</given-names> </author><author><surname>Forster</surname> <given-names>J.</given-names> </author><author><surname>Damjanov</surname> <given-names>I.</given-names> </author><author><surname>Hou</surname> <given-names>Q.</given-names> </author><author><surname>McCallum</surname> <given-names>R.W.</given-names> </author><title>Association of the status of interstitial cells of Cajal and electrogastrogram parameters, gastric emptying and symptoms in patients with gastroparesis</title><source>Neurogastroenterol Motil.</source><year>2009</year><volume>22</volume><fpage>56</fpage><lpage>61</lpage>
<author><surname>Pasricha</surname> <given-names>P.J.</given-names> </author><author><surname>Pehlivanov</surname> <given-names>N.</given-names> </author><author><surname>Sugumar</surname> <given-names>A.</given-names> </author><author><surname>Jankovic</surname> <given-names>J.</given-names> </author><title>Drug insight: from disturbed motility to disordered movement: a review of the clinical benefits and medicolegal risks of metoclopramide</title><source>Nat Clin Pract Gastroenterol Hepatol.</source><year>2006</year><volume>3</volume><fpage>138</fpage><lpage>148</lpage>
<author><surname>Fraser</surname> <given-names>R.J.</given-names> </author><author><surname>Horowitz</surname> <given-names>M.</given-names> </author><author><surname>Maddox</surname> <given-names>A.F.</given-names> </author><author><surname>Harding</surname> <given-names>P.E.</given-names> </author><author><surname>Chatterton</surname> <given-names>B.E.</given-names> </author><author><surname>Dent</surname> <given-names>J.</given-names> </author><title>Hyperglycaemia slows gastric emptying in type 1 (insulin.dependent) diabetes mellitus</title><source>Diabetologia</source><year>1990</year><volume>33</volume><fpage>675</fpage><lpage>680</lpage>
<author><surname>Sogabe</surname> <given-names>M.</given-names> </author><author><surname>Okahisa</surname> <given-names>T.</given-names> </author><author><surname>Tsujigami</surname> <given-names>K.</given-names> </author><title>Ultrasonographic assessment of gastric motility in diabetic gastroparesis before and after attaining glycemic control</title><source>J Gastroenterol.</source><year>2005</year><volume>40</volume><fpage>583</fpage><lpage>590</lpage>
<author><surname>Schvarcz</surname> <given-names>E.</given-names> </author><author><surname>Palm&#233;r</surname> <given-names>M.</given-names> </author><author><surname>Aman</surname> <given-names>J.</given-names> </author><author><surname>Lindkvist</surname> <given-names>B.</given-names> </author><author><surname>Beckman</surname> <given-names>K.W.</given-names> </author><title>Hypoglycaemia increases the gastric emptying rate in patients with type 1 diabetes mellitus</title><source>Diabetic Med.</source><year>1993</year><volume>10</volume><fpage>660</fpage><lpage>663</lpage>
<author><surname>Schvarcz</surname> <given-names>E.</given-names> </author><author><surname>Palm&#233;r</surname> <given-names>M.</given-names> </author><author><surname>Aman</surname> <given-names>J.</given-names> </author><author><surname>Berne</surname> <given-names>C.</given-names> </author><title>Hypoglycemia increases the gastric emptying rate in healthy subjects</title><source>Diabetes Care</source><year>1995</year><volume>18</volume><fpage>674</fpage><lpage>676</lpage>
<author><surname>Miller</surname> <given-names>G.</given-names> </author><author><surname>Palmer</surname> <given-names>K.R.</given-names> </author><author><surname>Smith</surname> <given-names>B.</given-names> </author><author><surname>Ferrington</surname> <given-names>C.</given-names> </author><author><surname>Merrick</surname> <given-names>M.V.</given-names> </author><title>Smoking delays gastric emptying of solids</title><source>Gut</source><year>1989</year><volume>30</volume><fpage>50</fpage><lpage>53</lpage>
<author><surname>Jones</surname> <given-names>K.L.</given-names> </author><author><surname>Russo</surname> <given-names>A.</given-names> </author><author><surname>Stevens</surname> <given-names>J.E.</given-names> </author><author><surname>Wishart</surname> <given-names>J.M.</given-names> </author><author><surname>Berry</surname> <given-names>M.K.</given-names> </author><author><surname>Horowitz</surname> <given-names>M.</given-names> </author><title>Predictors of delayed gastric emptying in diabetes</title><source>Diabetes Care</source><year>2001</year><volume>24</volume><fpage>1264</fpage><lpage>1269</lpage>
<author><surname>Abell</surname> <given-names>T.L.</given-names> </author><author><surname>Camilleri</surname> <given-names>M.</given-names> </author><author><surname>Donohoe</surname> <given-names>K.</given-names> </author><title>Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine</title><source>J Nucl Med Technol.</source><year>2008</year><volume>36</volume><fpage>44</fpage><lpage>54</lpage>
<author><surname>Eliasson</surname> <given-names>B.</given-names> </author><author><surname>Bj&#246;rnsson</surname> <given-names>E.</given-names> </author><author><surname>Urbanavicius</surname> <given-names>V.</given-names> </author><title>Hyperinsulinaemia impairs gastrointestinal motility and slows carbohydrate absorption</title><source>Diabetologia</source><year>1995</year><volume>38</volume><fpage>79</fpage><lpage>85</lpage>
<author><surname>Watkins</surname> <given-names>C.C.</given-names> </author><author><surname>Sawa</surname> <given-names>A.</given-names> </author><author><surname>Jaffrey</surname> <given-names>S.</given-names> </author><title>Insulin restores neuronal nitric oxide synthase expression and function that is lost in diabetic gastropathy</title><source>J Clin Invest.</source><year>2000</year><volume>106</volume><fpage>373</fpage><lpage>384</lpage>
<author><surname>Bunck</surname> <given-names>M.C.</given-names> </author><author><surname>Diamant</surname> <given-names>M.</given-names> </author><author><surname>Corn&#233;r</surname> <given-names>A.</given-names> </author><title>One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial</title><source>Diabetes Care</source><year>2009</year><volume>32</volume><fpage>762</fpage><lpage>768</lpage>
<author><surname>Heine</surname> <given-names>R.J.</given-names> </author><author><surname>Gaal</surname> <given-names>L.F.</given-names> </author><author><surname>Johns</surname> <given-names>D.</given-names> </author><title>Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial</title><source>Ann Intern Med.</source><year>2005</year><volume>143</volume><fpage>559</fpage><lpage>569</lpage>
<author><surname>Little</surname> <given-names>T.J.</given-names> </author><author><surname>Pilichiewicz</surname> <given-names>A.N.</given-names> </author><author><surname>Russo</surname> <given-names>A.</given-names> </author><title>Effects of intravenous glucagon-like peptide-1 on gastric emptying and intragastric distribution in healthy subjects: relationships with postprandial glycemic and insulinemic responses</title><source>J Clin Endocrinol Metab.</source><year>2006</year><volume>91</volume><fpage>1916</fpage><lpage>1923</lpage>
<author><surname>Vella</surname> <given-names>A.</given-names> </author><author><surname>Lee</surname> <given-names>J.S.</given-names> </author><author><surname>Camilleri</surname> <given-names>M.</given-names> </author><title>Effects of pramlintide, an amylin analogue, on gastric emptying in type 1 and 2 diabetes mellitus</title><source>Neurogastroenterol Motil.</source><year>2002</year><volume>14</volume><fpage>123</fpage><lpage>131</lpage>
<author><surname>Samsom</surname> <given-names>M.</given-names> </author><author><surname>Szarka</surname> <given-names>L.A.</given-names> </author><author><surname>Camilleri</surname> <given-names>M.</given-names> </author><author><surname>Vella</surname> <given-names>A.</given-names> </author><author><surname>Zinsmeister</surname> <given-names>A.R.</given-names> </author><author><surname>Rizza</surname> <given-names>R.A.</given-names> </author><title>Pramlintide, an amylin analog, selectively delays gastric emptying: potential role of vagal inhibition</title><source>Am J Physiol Gastrointest Liver Physiol.</source><year>2000</year><volume>278</volume><fpage>946</fpage><lpage>951</lpage>
<author><surname>Koch</surname> <given-names>C.A.</given-names> </author><author><surname>Uwaifo</surname> <given-names>G.I.</given-names> </author><title>Are gastrointestinal symptoms related to diabetes mellitus and glycemic control?</title><source>Eur J Gastroenterol Hepatol.</source><year>2008</year><volume>20</volume><fpage>822</fpage><lpage>825</lpage>
<author><surname>Heine</surname> <given-names>R.J.</given-names> </author><author><surname>Brodows</surname> <given-names>R.</given-names> </author><title>Diabetic gastroparesis</title><source>N Engl J Med.</source><year>2007</year><volume>357</volume><fpage>418</fpage><lpage>420</lpage>
<author><surname>Longstreth</surname> <given-names>G.F.</given-names> </author><author><surname>Malagelada</surname> <given-names>J.R.</given-names> </author><author><surname>Kelly</surname> <given-names>K.A.</given-names> </author><title>Metoclopramide stimulation of gastric motility and emptying in diabetic gastroparesis</title><source>Ann Intern Med.</source><year>1977</year><volume>86</volume><fpage>195</fpage><lpage>196</lpage>
<author><surname>Perkel</surname> <given-names>M.S.</given-names> </author><author><surname>Moore</surname> <given-names>C.</given-names> </author><author><surname>Hersh</surname> <given-names>T.</given-names> </author><author><surname>Davidson</surname> <given-names>E.D.</given-names> </author><title>Metoclopramide therapy in patients with delayed gastric emptying: a randomized, double-blind study</title><source>Dig Dis Sci.</source><year>1979</year><volume>24</volume><fpage>662</fpage><lpage>666</lpage>
<author><surname>Peringer</surname> <given-names>E.</given-names> </author><author><surname>Jenner</surname> <given-names>P.</given-names> </author><author><surname>Marsden</surname> <given-names>C.D.</given-names> </author><title>Effect of metoclopramide on turnover of brain dopamine noradrenaline and 5-hydroxytryptamine</title><source>J Pharm Pharmacol.</source><year>1975</year><volume>27</volume><fpage>442</fpage><lpage>444</lpage>
<author><surname>Koch</surname> <given-names>K.</given-names> </author><title>Diabetic gastropathy: gastric neuromuscular dysfunction in diabetes mellitus: a review of symptoms, pathophysiology, and tretment</title><source>Dig Dis Sci.</source><year>1999</year><volume>44</volume><fpage>1061</fpage><lpage>1075</lpage>
<author><surname>Schade</surname> <given-names>R.R.</given-names> </author><author><surname>Dugas</surname> <given-names>M.C.</given-names> </author><author><surname>Lhotsky</surname> <given-names>D.M.</given-names> </author><author><surname>Gavaler</surname> <given-names>J.S.</given-names> </author><author><surname>Thiel</surname> <given-names>D.H.</given-names> </author><title>Effect of metoclopramide on gastric liquid emptying in patients with diabetic gastroparesis</title><source>Dig Dis Sci.</source><year>1985</year><volume>30</volume><fpage>10</fpage><lpage>15</lpage>
<author><surname>Erbas</surname> <given-names>T.</given-names> </author><author><surname>Varoglu</surname> <given-names>E.</given-names> </author><author><surname>Erbas</surname> <given-names>B.</given-names> </author><author><surname>Tastekin</surname> <given-names>G.</given-names> </author><author><surname>Akalin</surname> <given-names>S.</given-names> </author><title>Comparison of metoclopramide and erythromycin in the treatment of diabetic gastroparesis</title><source>Diabetes Care</source><year>1993</year><volume>16</volume><fpage>1511</fpage><lpage>1514</lpage>
<author><surname>McCallum</surname> <given-names>R.W.</given-names> </author><author><surname>Ricci</surname> <given-names>D.A.</given-names> </author><author><surname>Rakatansky</surname> <given-names>H.</given-names> </author><title>A multicenter placebo-controlled clinical trial of oral metoclopramide in diabetic gastroparesis</title><source>Diabetes Care</source><year>1983</year><volume>6</volume><fpage>463</fpage><lpage>467</lpage>
<author><surname>Ricci</surname> <given-names>D.A.</given-names> </author><author><surname>Saltzman</surname> <given-names>M.B.</given-names> </author><author><surname>Meyer</surname> <given-names>C.</given-names> </author><author><surname>Callachan</surname> <given-names>C.</given-names> </author><author><surname>McCallum</surname> <given-names>R.W.</given-names> </author><title>Effect of metoclopramide in diabetic gastroparesis</title><source>J Clin Gastroenterol.</source><year>1985</year><volume>7</volume><fpage>25</fpage><lpage>32</lpage>
<author><surname>Snape</surname> <given-names>W.J.</given-names> <suffix>Jr.</suffix> </author><author><surname>Battle</surname> <given-names>W.M.</given-names> </author><author><surname>Schwartz</surname> <given-names>S.S.</given-names> </author><author><surname>Braunstein</surname> <given-names>S.N.</given-names> </author><author><surname>Goldstein</surname> <given-names>H.A.</given-names> </author><author><surname>Alavi</surname> <given-names>A.</given-names> </author><title>Metoclopramide to treat gastroparesis due to diabetes mellitus</title><source>Ann Intern Med.</source><year>1982</year><volume>96</volume><fpage>444</fpage><lpage>446</lpage>
<author><surname>Talley</surname> <given-names>N.</given-names> </author><title>Diabetic gastropathy and prokinetics</title><source>Am J Gastroenterol.</source><year>2003</year><volume>98</volume><fpage>264</fpage><lpage>271</lpage>
<author><surname>Tonini</surname> <given-names>M.</given-names> </author><author><surname>Cipolina</surname> <given-names>L.</given-names> </author><author><surname>Poluuzzi</surname> <given-names>E.</given-names> </author><title>Clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics</title><source>Aliment Pharmacol Ther.</source><year>2004</year><volume>19</volume><fpage>379</fpage><lpage>390</lpage>
<author><surname>Parkman</surname> <given-names>H.P.</given-names> </author><title>American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis</title><source>Gastroenterology</source><year>2004</year><volume>127</volume><fpage>1592</fpage><lpage>1622</lpage>
<author><surname>Patterson</surname> <given-names>D.</given-names> </author><author><surname>Abell</surname> <given-names>T.</given-names> </author><author><surname>Rothstein</surname> <given-names>R.</given-names> </author><author><surname>Koch</surname> <given-names>K.</given-names> </author><author><surname>Barnett</surname> <given-names>J.</given-names> </author><title>A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis</title><source>Am J Gastroenterol.</source><year>1999</year><volume>94</volume><fpage>1230</fpage><lpage>1234</lpage>
<author><surname>Farup</surname> <given-names>C.E.</given-names> </author><author><surname>Leidy</surname> <given-names>N.K.</given-names> </author><author><surname>Murray</surname> <given-names>M.</given-names> </author><author><surname>Williams</surname> <given-names>G.R.</given-names> </author><author><surname>Helbers</surname> <given-names>L.</given-names> </author><author><surname>Quigley</surname> <given-names>E.M.</given-names> </author><title>Effect of domperidone on the health-related quality of life of patients with symptoms of diabetic gastroparesis</title><source>Diabetes Care</source><year>1998</year><volume>21</volume><fpage>1699</fpage><lpage>1706</lpage>
<author><surname>Heer</surname> <given-names>M.</given-names> </author><author><surname>Muller-Duysing</surname> <given-names>W.</given-names> </author><author><surname>Benes</surname> <given-names>I.</given-names> </author><title>Diabetic gastroparesis: treatment with domperidone &#8212; a double-blind, placebo-controlled trial</title><source>Digestion</source><year>1983</year><volume>27</volume><fpage>214</fpage><lpage>217</lpage>
<author><surname>Champion</surname> <given-names>E.A.</given-names> </author><title>Domperidone (Motilium) improves symptoms and solid phase gastric emptying in diabetic gastroparesis</title><source>Gastroenterol.</source><year>1987</year><volume>82</volume><fpage>975</fpage>
<author><surname>Dumitrascu</surname> <given-names>D.L.</given-names> </author><author><surname>Weinbeck</surname> <given-names>M.</given-names> </author><title>Domperidone versus metoclopramide in the treatment of diabetic gastroparesis</title><source>Am J Gastroenterol.</source><year>2000</year><volume>95</volume><fpage>316</fpage><lpage>317</lpage>
<author><surname>Sugumar</surname> <given-names>A.</given-names> </author><author><surname>Singh</surname> <given-names>A.</given-names> </author><author><surname>Pasricha</surname> <given-names>P.J.</given-names> </author><title>A systematic review of the efficacy of domperidone for the treatment of diabetic gastroparesis</title><source>Clin Gastroenterol Hepatol.</source><year>2008</year><volume>6</volume><fpage>726</fpage><lpage>733</lpage>
<author><surname>Camilleri</surname> <given-names>M.</given-names> </author><title>Clinical practice. Diabetic gastroparesis</title><source>N Engl J Med.</source><year>2007</year><volume>356</volume><fpage>820</fpage><lpage>829</lpage>
<author><surname>Richards</surname> <given-names>R.D.</given-names> </author><author><surname>Davenport</surname> <given-names>K.</given-names> </author><author><surname>McCallum</surname> <given-names>R.W.</given-names> </author><title>The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin</title><source>Am J Gastroenterol.</source><year>1993</year><volume>88</volume><fpage>203</fpage><lpage>207</lpage>
<author><surname>Janssens</surname> <given-names>J.</given-names> </author><author><surname>Peeters</surname> <given-names>T.L.</given-names> </author><author><surname>Vantrappen</surname> <given-names>G.</given-names> </author><title>Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies</title><source>N Engl J Med.</source><year>1990</year><volume>322</volume><fpage>1028</fpage><lpage>1031</lpage>
<author><surname>Dive</surname> <given-names>A.</given-names> </author><author><surname>Miesse</surname> <given-names>C.</given-names> </author><author><surname>Galanti</surname> <given-names>L.</given-names> </author><title>Effect of erythromycin on gastric motility in mechanically ventilated critically ill patients: a double-blind, randomized, placebo-controlled study</title><source>Crit Care Med.</source><year>1995</year><volume>23</volume><fpage>1356</fpage><lpage>1362</lpage>
<author><surname>Talley</surname> <given-names>N.J.</given-names> </author><author><surname>Verlinden</surname> <given-names>M.</given-names> </author><author><surname>Geenen</surname> <given-names>D.J.</given-names> </author><title>Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial</title><source>Gut</source><year>2001</year><volume>49</volume><fpage>395</fpage><lpage>401</lpage>
<author><surname>Talley</surname> <given-names>N.J.</given-names> </author><author><surname>Verlinden</surname> <given-names>M.</given-names> </author><author><surname>Snape</surname> <given-names>W.</given-names> </author><title>Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial</title><source>Aliment Pharmacol Ther.</source><year>2000</year><volume>14</volume><fpage>1653</fpage><lpage>1661</lpage>
<author><surname>McCallum</surname> <given-names>R.W.</given-names> </author><author><surname>Cynshi</surname> <given-names>O.</given-names> </author><title>Clinical trial: effect of mitemcinal (a motilin agonist) on gastric emptying in patients with gastroparesis &#8212; a randomized, multicentre, placebo-controlled study</title><source>Aliment Pharmacol Ther.</source><year>2007</year><volume>26</volume><fpage>1121</fpage><lpage>1130</lpage>
<author><surname>Hawkyard</surname> <given-names>C.V.</given-names> </author><author><surname>Koerner</surname> <given-names>R.J.</given-names> </author><title>The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks</title><source>J Antimicrob Chemother.</source><year>2007</year><volume>59</volume><fpage>347</fpage><lpage>358</lpage>
<author><surname>McCallum</surname> <given-names>R.W.</given-names> </author><author><surname>Prakash</surname> <given-names>C.</given-names> </author><author><surname>Campoli-Richards</surname> <given-names>D.M.</given-names> </author><author><surname>Goa</surname> <given-names>K.L.</given-names> </author><title>Cisapride. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal disorders</title><source>Drugs</source><year>1988</year><volume>36</volume><fpage>652</fpage><lpage>681</lpage>
<author><surname>Champion</surname> <given-names>M.C.</given-names> </author><title>Management of idiopathic, diabetic and miscellaneous gastroparesis with cisapride</title><source>Scand J Gastroenterol Suppl.</source><year>1989</year><volume>165</volume><fpage>44</fpage><lpage>52</lpage>
<author><surname>Horowitz</surname> <given-names>M.</given-names> </author><author><surname>Maddern</surname> <given-names>G.J.</given-names> </author><author><surname>Maddox</surname> <given-names>A.</given-names> </author><author><surname>Wishart</surname> <given-names>J.</given-names> </author><author><surname>Chatterton</surname> <given-names>B.E.</given-names> </author><author><surname>Shearman</surname> <given-names>D.J.</given-names> </author><title>Effects of cisapride on gastric and esophageal emptying in progressive systemic sclerosis</title><source>Gastroenterology</source><year>1987</year><volume>93</volume><fpage>311</fpage><lpage>315</lpage>
<author><surname>Horowitz</surname> <given-names>M.</given-names> </author><author><surname>Maddox</surname> <given-names>A.</given-names> </author><author><surname>Harding</surname> <given-names>P.E.</given-names> </author><title>Effect of cisapride on gastric and esophageal emptying in insulin-dependent diabetes mellitus</title><source>Gastroenterology</source><year>1987</year><volume>92</volume><fpage>1899</fpage><lpage>1907</lpage>
<author><surname>McHugh</surname> <given-names>S.</given-names> </author><author><surname>Lico</surname> <given-names>S.</given-names> </author><author><surname>Diamant</surname> <given-names>N.E.</given-names> </author><title>Cisapride vs. metoclopramide</title><source>Dig Dis Sci.</source><year>1992</year><volume>37</volume><fpage>997</fpage><lpage>1001</lpage>
<author><surname>Havelund</surname> <given-names>T.</given-names> </author><author><surname>Oster-J&#248;rgensen</surname> <given-names>E.</given-names> </author><author><surname>Esh&#248;j</surname> <given-names>O.</given-names> </author><author><surname>Larsen</surname> <given-names>M.L.</given-names> </author><author><surname>Lauritsen</surname> <given-names>K.</given-names> </author><title>Effects of cisapride on gastroparesis in patients with insulin-dependent diabetes mellitus</title><source>Acta Medica Scandinavica</source><year>1987</year><volume>222</volume><fpage>339</fpage><lpage>343</lpage>
<author><surname>Takaya</surname> <given-names>K.</given-names> </author><author><surname>Ariyasu</surname> <given-names>H.</given-names> </author><author><surname>Kanamoto</surname> <given-names>N.</given-names> </author><title>Ghrelin strongly stimulates growth hormone release in humans</title><source>J Clin Endocrinol Metab.</source><year>2000</year><volume>85</volume><fpage>4908</fpage><lpage>4911</lpage>
<author><surname>Peino</surname> <given-names>R.</given-names> </author><author><surname>Baldelli</surname> <given-names>R.</given-names> </author><author><surname>Rodriguez-Garcia</surname> <given-names>J.</given-names> </author><title>Ghrelin-induced growth hormone secretion in humans</title><source>Eur J Endocrinol.</source><year>2000</year><volume>143</volume><fpage>R11</fpage><lpage>R14</lpage>
<author><surname>Date</surname> <given-names>Y.</given-names> </author><author><surname>Kojima</surname> <given-names>M.</given-names> </author><author><surname>Hosoda</surname> <given-names>H.</given-names> </author><title>Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans</title><source>Endocrinology</source><year>2000</year><volume>141</volume><fpage>4255</fpage><lpage>4261</lpage>
<author><surname>Kojima</surname> <given-names>M.</given-names> </author><author><surname>Hosoda</surname> <given-names>H.</given-names> </author><author><surname>Date</surname> <given-names>Y.</given-names> </author><author><surname>Nakazato</surname> <given-names>M.</given-names> </author><author><surname>Matsuo</surname> <given-names>H.</given-names> </author><author><surname>Kangawa</surname> <given-names>K.</given-names> </author><title>Ghrelin is a growth-hormone-releasing acylated peptide from stomach</title><source>Nature</source><year>1999</year><volume>402</volume><fpage>656</fpage><lpage>660</lpage>
<author><surname>Howard</surname> <given-names>A.D.</given-names> </author><author><surname>Feighner</surname> <given-names>S.D.</given-names> </author><author><surname>Cully</surname> <given-names>D.F.</given-names> </author><title>A receptor in pituitary and hypothalamus that functions in growth hormone release</title><source>Science</source><year>1996</year><volume>273</volume><fpage>974</fpage><lpage>977</lpage>
<author><surname>Tack</surname> <given-names>J.</given-names> </author><author><surname>Depoortere</surname> <given-names>I.</given-names> </author><author><surname>Bisschops</surname> <given-names>R.</given-names> </author><title>Influence of ghrelin on interdigestive gastrointestinal motility in humans</title><source>Gut</source><year>2006</year><volume>55</volume><fpage>327</fpage><lpage>333</lpage>
<author><surname>Wren</surname> <given-names>A.M.</given-names> </author><author><surname>Seal</surname> <given-names>L.J.</given-names> </author><author><surname>Cohen</surname> <given-names>M.A.</given-names> </author><title>Ghrelin enhances appetite and increases food intake in humans</title><source>J Clin Endocrinol Metab.</source><year>2001</year><volume>86</volume><fpage>5992</fpage>
<author><surname>Druce</surname> <given-names>M.R.</given-names> </author><title>Ghrelin increases food intake in obese as well as lean subjects</title><source>Int J Obes (Lond).</source><year>2005</year><volume>29</volume><fpage>1130</fpage><lpage>1136</lpage>
<author><surname>Strasser</surname> <given-names>F.</given-names> </author><author><surname>Lutz</surname> <given-names>T.A.</given-names> </author><author><surname>Maeder</surname> <given-names>M.T.</given-names> </author><title>Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia/cachexia: a randomised, placebo-controlled, double-blind, double-crossover study</title><source>Br J Cancer</source><year>2008</year><volume>98</volume><fpage>300</fpage><lpage>308</lpage>
<author><surname>Murray</surname> <given-names>C.D.</given-names> </author><author><surname>Martin</surname> <given-names>N.M.</given-names> </author><author><surname>Patterson</surname> <given-names>M.</given-names> </author><title>Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study</title><source>Gut</source><year>2005</year><volume>54</volume><fpage>1693</fpage><lpage>1698</lpage>
<author><surname>Popescu</surname> <given-names>I.</given-names> </author><author><surname>Fleshner</surname> <given-names>P.R.</given-names> </author><author><surname>Pezzullo</surname> <given-names>J.C.</given-names> </author><author><surname>Charlton</surname> <given-names>P.A.</given-names> </author><author><surname>Kosutic</surname> <given-names>G.</given-names> </author><author><surname>Senagore</surname> <given-names>A.J.</given-names> </author><title>The Ghrelin agonist TZP-101 for management of postoperative ileus after partial colectomy: a randomized, dose-ranging, placebo-controlled clinical trial</title><source>Dis Colon Rectum</source><year>2010</year><volume>53</volume><fpage>126</fpage><lpage>134</lpage>
<author><surname>Ejskjaer</surname> <given-names>N.</given-names> </author><author><surname>Vestergaard</surname> <given-names>E.T.</given-names> </author><author><surname>Hellstr&#246;m</surname> <given-names>P.M.</given-names> </author><title>Ghrelin receptor agonist (TZP-101) accelerates gastric emptying in adults with diabetes and symptomatic gastroparesis</title><source>Aliment Pharmacol Ther.</source><year>2009</year><volume>29</volume><fpage>1179</fpage><lpage>1187</lpage>
<author><surname>Lasseter</surname> <given-names>K.C.</given-names> </author><author><surname>Shaughnessy</surname> <given-names>L.</given-names> </author><author><surname>Cummings</surname> <given-names>D.</given-names> </author><title>Ghrelin agonist (TZP-101): safety, pharmacokinetics and pharmacodynamic evaluation in healthy volunteers: a phase I, first-in-human study</title><source>J Clin Pharmacol.</source><year>2008</year><volume>48</volume><fpage>193</fpage><lpage>202</lpage>
<author><surname>Wang</surname> <given-names>C.P.</given-names> </author><author><surname>Kao</surname> <given-names>C.H.</given-names> </author><author><surname>Chen</surname> <given-names>W.K.</given-names> </author><author><surname>Lo</surname> <given-names>W.Y.</given-names> </author><author><surname>Hsieh</surname> <given-names>C.L.</given-names> </author><title>A single-blinded, randomized pilot study evaluating effects of electroacupuncture in diabetic patients with symptoms suggestive of gastroparesis</title><source>J Altern Complement Med.</source><year>2008</year><volume>14</volume><fpage>833</fpage><lpage>839</lpage>
<author><surname>Mearin</surname> <given-names>F.</given-names> </author><author><surname>Camilleri</surname> <given-names>M.</given-names> </author><author><surname>Malagelada</surname> <given-names>J.R.</given-names> </author><title>Pyloric dysfunction in diabetics with recurrent nausea and vomiting</title><source>Gastroenterology</source><year>1986</year><volume>90</volume><fpage>1919</fpage><lpage>1925</lpage>
<author><surname>Camilleri</surname> <given-names>M.</given-names> </author><author><surname>Brown</surname> <given-names>M.L.</given-names> </author><author><surname>Malagelada</surname> <given-names>J.R.</given-names> </author><title>Relationship between impaired gastric emptying and abnormal gastrointestinal motility</title><source>Gastroenterology</source><year>1986</year><volume>91</volume><fpage>94</fpage><lpage>99</lpage>
<author><surname>Jankovic</surname> <given-names>J.</given-names> </author><author><surname>Brin</surname> <given-names>M.F.</given-names> </author><title>Therapeutic uses of botulinum toxin</title><source>N Engl J Med.</source><year>1991</year><volume>324</volume><fpage>1186</fpage><lpage>1194</lpage>
<author><surname>Pehlivanov</surname> <given-names>N.</given-names> </author><author><surname>Pasricha</surname> <given-names>P.J.</given-names> </author><title>Achalasia: botox, dilatation or laparoscopic surgery in 2006</title><source>Neurogastroenterol Motil.</source><year>2006</year><volume>18</volume><fpage>799</fpage><lpage>804</lpage>
<author><surname>Park</surname> <given-names>M.I.</given-names> </author><author><surname>Camilleri</surname> <given-names>M.</given-names> </author><title>Gastroparesis: clinical update</title><source>Am J Gastroenterol</source><year>2006</year><volume>101</volume><fpage>1129</fpage><lpage>1139</lpage>
<author><surname>Arts</surname> <given-names>J.</given-names> </author><author><surname>Holvoet</surname> <given-names>L.</given-names> </author><author><surname>Caenepeel</surname> <given-names>P.</given-names> </author><title>Clinical trial: a randomized-controlled crossover study of intrapyloric injection of botulinum toxin in gastroparesis</title><source>Aliment Pharmacol Ther.</source><year>2007</year><volume>26</volume><fpage>1251</fpage><lpage>1258</lpage>
<author><surname>Friedenberg</surname> <given-names>F.K.</given-names> </author><author><surname>Palit</surname> <given-names>A.</given-names> </author><author><surname>Parkman</surname> <given-names>H.P.</given-names> </author><author><surname>Hanlon</surname> <given-names>A.</given-names> </author><author><surname>Nelson</surname> <given-names>D.B.</given-names> </author><title>Botulinum toxin A for the treatment of delayed gastric emptying</title><source>Am J Gastroenterol.</source><year>2008</year><volume>103</volume><fpage>416</fpage><lpage>423</lpage>
<url>http://www.nice.org.uk/nicemedia/live/11130/31200/31200.pdf</url>
<author><surname>Anand</surname> <given-names>C.</given-names> </author><author><surname>Al-Juburi</surname> <given-names>A.</given-names> </author><author><surname>Familoni</surname> <given-names>B.</given-names> </author><title>Gastric electrical stimulation is safe and effective: a long-term study in patients with drug-refractory gastroparesis in three regional centers</title><source>Digestion</source><year>2007</year><volume>75</volume><fpage>83</fpage><lpage>89</lpage>
<author><surname>Abell</surname> <given-names>T.L.</given-names> </author><author><surname>Malinowski</surname> <given-names>S.</given-names> </author><author><surname>Minocha</surname> <given-names>A.</given-names> </author><title>Nutrition aspects of gastroparesis and therapies for drug-refractory patients</title><source>Nutr Clin Pract.</source><year>2006</year><volume>21</volume><fpage>23</fpage><lpage>33</lpage>
<author><surname>Cutts</surname> <given-names>T.F.</given-names> </author><author><surname>Luo</surname> <given-names>J.</given-names> </author><author><surname>Starkebaum</surname> <given-names>W.</given-names> </author><author><surname>Rashed</surname> <given-names>H.</given-names> </author><author><surname>Abell</surname> <given-names>T.L.</given-names> </author><title>Is gastric electrical stimulation superior to standard pharmacologic therapy in improving GI symptoms, healthcare resources, and long-term health care benefits?</title><source>Neurogastroenterol Motil.</source><year>2005</year><volume>17</volume><fpage>35</fpage><lpage>43</lpage>
<author><surname>Maranki</surname> <given-names>J.</given-names> </author><author><surname>Parkman</surname> <given-names>H.P.</given-names> </author><title>Gastric electric stimulation for the treatment of gastroparesis</title><source>Curr Gastroenterol Rep.</source><year>2007</year><volume>9</volume><fpage>286</fpage><lpage>294</lpage>
<author><surname>Maranki</surname> <given-names>J.L.</given-names> </author><author><surname>Lytes</surname> <given-names>V.</given-names> </author><author><surname>Meilahn</surname> <given-names>J.E.</given-names> </author><title>Predictive factors for clinical improvement with Enterra gastric electric stimulation treatment for refractory gastroparesis</title><source>Dig Dis Sci.</source><year>2008</year><volume>53</volume><fpage>2072</fpage><lpage>2078</lpage>
<author><surname>Jones</surname> <given-names>M.P.</given-names> </author><author><surname>Maganti</surname> <given-names>K.</given-names> </author><title>A systematic review of surgical therapy for gastroparesis</title><source>Am J Gastroenterol.</source><year>2003</year><volume>98</volume><fpage>2122</fpage><lpage>2129</lpage>